After stratifying patients into groups with high and low expression (relative to the mean expression of HNF4A in the tumor samples), we found that low HNF4A expression is associated with shorter survival in KIRC patients (Fig 4D, log-rank p-value 0.007). Here, HNF4A is linked to neoplasm.